Description
Drugs of Abuse is an important growth category in IVD testing with competitive participation by top IVD vendors for market share. Healthcare professionals, employers, criminal justice personnel, and sports use drug tests as part of a comprehensive evaluation of individuals to reach a correct decision regarding the individuals’ actions, behaviors or performances. This report covers trends and markets in drugs of abuse testing. As part of its coverage, the report offers estimates and forecasts for drugs of abuse markets, and the following market segment estimates:
Market by Type of Sample (Urine, Oral, Blood, Hair)
Market by Application, including:
Employment
Criminal Justice
Lab-based IVD
Professional POC
Home OTC
Market by Region (US, EUR, ROW)
Market Share by Provider
The report’s geographic scope is worldwide with information for specific geographical regions; world demographics;, and other general issues affecting the market The market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included. The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.
Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 12 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
A group of diversified companies is involved in the development or marketing of drugs of abuse testing and technology products. The market is considered evolving with growth opportunity. Drug abuse is a worldwide problem and it is growing. Key companies such as Roche Diagnostics, Abbott Diagnostics and Siemens Healthcare will likely maintain leading positions in the market through continued product innovation and strategic alliances and mergers. Among the top and/or innovative competitors discussed within Corporate Profiles are:
- 1st Step Detect Associates
- Abbott Diagnostics
- AccuTech
- Alere
- Alfa Scientific
- Amedica Biotech
- American Bio Medica
- Atlas Link Biotech
- Beckman Coulter
- Biophor Diagnostics
- Bio-Medical Products
- Bio-Rad Laboratories
- BioScan Screening Systems
- Branan Medical Corp
- Confirm Biosciences
- DeVon Medical Products
- IDenta Corp
- Lifeloc Technologies
- LifeSign
- MAVAND Solutions
- MedTest Dx
- Mossman Associates
- MP BioMedicals
- Nano-Ditech Corp
- OraSure
- Ortho Clinical Diagnostics
- Polymed Therapeutics
- PreChek Bio
- Princeton Biomedtech
- Psychemedics
- Randox Laboratories
- Redwood Toxicology
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
- UCP Biosciences
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting Market
Leading Competitors
CHAPTER TWO: INTRODUCTION
Overview
Club Drugs
GHB
Rohypnol
Ketamine
Narcotic Abuse
Heroin
Narcotic Analgesics
Opium
Central Nervous System Depressant Abuse
Sedative-Hypnotic/Antianxiety Abuse
Alcohol Abuse
Central Nervous system Stimulants
Amphetamine and Amphetamine-Like Agents
Ecstasy
Cocaine Abuse
Marijuana Abuse
Psychedelic Agents
Tobacco
Inhalant Abuse
Steroid Abuse
Miscellaneous Drugs of Abuse
Salvia
Bath Salts
Khat
DXM
World Demographics
Prevalence and Number of Illicit Drug Users
Types of Specimens Used for Drugs of Abuse Testing
Urine
Oral
Blood
Hair
Sweat
Drugs of Abuse Testing Situations
Employment
Medical Screening
Legal
Sports
Methods of Testing for Drugs
Immunoassays
Latex Agglutination
Lateral Flow
Radioimmunoassay
Fluorescence Polarization Immunoassay
EMIT
Chromatography
Thin-Layer Chromatography
High-Pressure Liquid Chromatography
Gas Chromatography
Gas Chromatography/Mass Spectrometry
CHAPTER THREE: DRUGS OF ABUSE TEST PRODUCTS
Urine
Oral
Blood
Hair
CHAPTER FOUR: DRUGS OF ABUSE MARKET AND COMPETITOR ANALYSIS
Market Overview
Market Analysis by Product Type
Market Analysis by Setting
Criminal/Justice
Lab-Based
Professional POC
Home OTC
Market Analysis by Region
US
EUR
ROW
Competitive Analysis
CHAPTER FIVE: ISSUES AND TRENDS
Technology Trends
Drug Testing and Welfare Recipients
Drugs of Abuse Testing and Technologies Market iii
New Illicit Drugs
Drug Test Adulteration
Regulatory Issues
California
Colorado
Iowa
New York
Florida
Industry Consolidation
Drugs and Sports
CHAPTER SIX: INDUSTRY MANUFACTURERS
Overview
1st Step Detect Associates, LLC
Abbott Diagnostics
AccuTech, LLC
Alere, Inc.
Alfa Scientific Designs, Inc
Amedica Biotech, Inc
American Bio Medica Corporation
Atlas Link Bioteck Co Ltd
Beckman Coulter, Inc
Biophor Diagnostics, Inc
Bio-Medical Products Corp
Bio-Rad Laboratories
BioScan Screening Sustems, Inc.
Branan Medical Corp
Confirm Biosciences
DeVon Medical Products
Identa Corp
Lifeloc Technologies
LifeSign, LLC
Mavand Solutions GmbH
MediTest DX
Mossman Associates
MP BioMedicals LLC
Nano-Ditech Corporation
Orasure Technologies, Inc
Ortho Clinical Diagnostics
Polymed Therapeutics Inc
PreChek Bio, Inc
Princeton Biomeditech Corporation
Psychemedics Corporation
Randox Laboratories Ltd
Redwood Toxicology Laboratory, Inc
Roche Diagnostics Corporation
Siemens Healthcare
Thermo Fisher Scientific, Inc
UCP Biosciences, Inc
APPENDIX: LIST OF MAJOR COMPANIES
TABLE OF FIGURES
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: Drugs of Abuse Testing and Technologies Market Analysis: 2011-2018
Figure 1-1: Drugs of Abuse Testing and Technologies Market Analysis: 2011-2018
CHAPTER TWO: INTRODUCTION
Table 2-1: Types of Inhalants
Table 2-2: Estimated World Population by Age and Geographical Region, 2012
Figure 2-1: Estimated World Population by Age and Geographical Region, 2012
Table 2-3: Annual Prevalence and Number of Illicit Drug Users Globally by Drug Type
Table 2-4: Estimated Number and Prevalence of Drug Users by Region and Age (15-64)
CHAPTER FOUR: DRUGS OF ABUSE MARKET AND COMPETITOR ANALYSIS
Table 4-1: Drugs of Abuse Testing and Technologies Market Analysis: 2011-2018
Figure 4-1: Drugs of Abuse Testing and Technologies Market Analysis: 2011-2018
Table 4-2: Drugs of Abuse Testing and Technologies Market Analysis by Test Type, 2013
Figure 4-2: Drugs of Abuse Testing and Technologies Market Analysis by Test Type, 2013
Table 4-3: Drugs of Abuse Testing and Technologies Market Analysis by Setting Type, 2013
Figure 4-3: Drugs of Abuse Testing and Technologies Market Analysis by Setting Type, 2013
Table 4-4: Drugs of Abuse Testing and Technologies Market Analysis by Region/Country, 2013
Figure 4-4: Drugs of Abuse Testing and Technologies Market Analysis by Region/Country, 2013
Table 4-5: Drugs of Abuse Testing and Technologies Market Revenues and Market Share of Leading Suppliers 2013
Figure 4-5: Drugs of Abuse Testing and Technologies Market Market Share by Leading Suppliers 2013
CHAPTER FIVE: ISSUES AND TRENDS
Table 5-1: Olympic Doping Cases 1968-2012
CHAPTER SIX: INDUSTRY MANUFACTURERS
